Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @OxfordOptronix
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @OxfordOptronix
-
Prikvačeni tweet
We have a full list of our upcoming trade shows and conferences for 2020 now live on our website. Oxford Optronix and its partners will be attending key global shows through the year. Keep up to date on main events: https://www.oxford-optronix.com/en/Shows-and-Conferences …
@ScinticaInstpic.twitter.com/osjrp322v5
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Acknowledging
#WorldCancerDay
, we at Oxford Optronix are committed to providing the latest #innovation and#technology to all our valued customers working in#cancerresearch.#WorldCancerDay
pic.twitter.com/1jk8bodobp
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hello 2020! As we stand before a new decade Oxford Optronix proudly celebrates a record-breaking 2019 and looks forward to delivering on an exciting
#pipeline of#newproducts and#productenhancements
For company news updates click here:
https://www.oxford-optronix.com/ournews/38/Here+comes+2020 …pic.twitter.com/XhjcuR7nJT
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Oxford Optronix proslijedio/la je Tweet
There are a variety of ways that researchers today can
#measure#oxygenation of#tissue#invivo. Unfortunately, while a range of options do exist, choosing which technology to use to measure tissue oxygenation is often difficult. Read entire#article
https://bit.ly/35iHCbL pic.twitter.com/zx6WpJ7byC
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Our laser-Doppler tissue blood flow monitors (OxyFlo) have been cited in 100s of scientific publications in applications ranging from
#cancerresearch to#stroke and#plasticsurgery. To check the full list of peer-reviewed articles: https://www.oxford-optronix.com/en/Blood-Flow-Monitors …pic.twitter.com/JSdYwPXlCL
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Oxford Optronix proslijedio/la je Tweet
'Why breast cancer genes need to be rebranded' — interesting article by
@BBC_Future that discusses recent#ProstateCancer research by Professor Ros Eeles (ICR &@royalmarsdenNHS):https://www.bbc.com/future/article/20200124-why-brca-cancer-genes-need-to-be-rebranded-for-men …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Our products are consistently awarded 5 stars for Ease-of-Use and Aftersales services on Select Science.




https://www.selectscience.net/suppliers/oxford-optronix?compID=8841 …
@SelectScienceHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Sepsis is featured in The Guardian. Oxford Optronix is proud to be taking part in an on-going clinical trial led by Prof. Singer at UCLH in which our WellBeing system is being used to detect impending shock states in the critically ill
@uclh@wellcometrusthttps://www.theguardian.com/society/2020/jan/16/sepsis-deaths-around-world-twice-as-high-as-previously-thought?CMP=Share_AndroidApp_Notepad_Free …Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Oxford Optronix is represented in four continents by companies that share our company's core values and principles. To see the full list of distributors click on: https://www.oxford-optronix.com/en/Distributors
@apac_scientific@ADInstruments@ScinticaInst@enjazmepic.twitter.com/HmhGF9tsA6
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Oxford Optronix proslijedio/la je Tweet
Machine learning could transform breast cancer screening in the NHS. Our latest blog post explains the ins and out of our research partnership with
@GoogleHealth and why this new AI development is so exciting
http://po.st/6Ge1lp pic.twitter.com/1FGnsqff2VHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Oxford Optronix proslijedio/la je Tweet
We hope you’ve enjoyed our list of scientific achievements that we've been tweeting about over the last two weeks! We look forward to making more breakthroughs next year to continue our mission to make the discoveries to
#DefeatCancer.#ICR10pic.twitter.com/SxL4kFepSJ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The holidays are very nearly here, so we wanted to take this opportunity to wish you all a very Merry Christmas, and we look forward to working with you next year.pic.twitter.com/TZ23Dshl44
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Oxford Optronix proslijedio/la je Tweet
New cancer research post in
@OxPrimaryCare open now for applications. https://my.corehr.com/pls/uoxrecruit/erq_jobspec_details_form.jobspec?p_id=144233 …pic.twitter.com/sGFHjGPpgB
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Data science to predict and prevent adverse drug reactions in children with cancer | Times Higher Education (
@timeshighered)https://www.timeshighereducation.com/hub/simon-fraser-university/p/data-science-predict-and-prevent-adverse-drug-reactions-children …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Oxford Optronix proslijedio/la je Tweet
We are now officially open for applications to the new Oxford University DPhil in Cancer Science Programme - more information about how to apply
http://bit.ly/2QPHZ9K pic.twitter.com/NFKGMVyycc
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Science Surgery from
@CR_UK: ‘Why do some cancers metastasise, but others don’t?’https://scienceblog.cancerresearchuk.org/2019/11/26/science-surgery-why-do-some-cancers-metastasise-but-others-dont/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Oxford Optronix proslijedio/la je Tweet
Routine surgeries are no longer available because of the threat of antimicrobial resistance. Post December 12, will the UK see a substantial
#AMR action plan? https://bit.ly/2KUSIvA pic.twitter.com/lKfBYUHOkr
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Oxford Optronix proslijedio/la je Tweet
The next five years are an opportunity for the next Government to make the UK a world leader in cancer prevention, diagnosis and care – but for that to happen we need to see some changes. Follow
@CRUK_Policy tonight, to follow our thoughts on the#BBCDebate.pic.twitter.com/fHoX6ZQ1HA
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Oxford Optronix proslijedio/la je Tweet
Why do some cancers metastasise, but others don’t? Read our Science Surgery post for the answer: http://po.st/BAWAbT pic.twitter.com/QC92Q7I05z
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Global Cell Counters Market 2019 – featuring Oxford Optronix https://industrynewsreport24.com/global-cell-counters-market-2019-thermo-fisher-scientific-bio-rad-beckman-coulter-countstar-merck-millipore/48681/ …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.